Cargando…
Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer’s Disease
Alzheimer’s Disease (AD) is a major health problem worldwide. The lack of efficacy of existing therapies for AD is because of diagnosis at late stages of the disease, limited knowledge of biomarkers, and molecular mechanisms of AD pathology, as well as conventional drugs that are focused on symptoma...
Autores principales: | Martínez-Iglesias, Olaia, Naidoo, Vinogran, Carrera, Iván, Cacabelos, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909965/ https://www.ncbi.nlm.nih.gov/pubmed/35269588 http://dx.doi.org/10.3390/ijms23052446 |
Ejemplares similares
-
Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer’s Disease
por: Carrera, Iván, et al.
Publicado: (2023) -
Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2023) -
Epigenetic Biomarkers as Diagnostic Tools for Neurodegenerative Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2021) -
Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2022) -
AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2022)